Moleculin Biotech (MBRX)
(Delayed Data from NSDQ)
$2.36 USD
-0.10 (-4.07%)
Updated Oct 4, 2024 04:00 PM ET
After-Market: $2.36 0.00 (0.00%) 7:58 PM ET
4-Sell of 5 4
F Value B Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/11/24 |
---|---|
Current Quarter | -2.44 |
EPS Last Quarter | -2.23 |
Last EPS Surprise | -6.19% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -7.48 |
Next Year | -5.87 |
EPS (TTM) | -13.64 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | NA | NA | NA | NA |
# of Estimates | NA | NA | NA | NA |
High Estimate | NA | NA | NA | NA |
Low Estimate | NA | NA | NA | NA |
Year ago Sales | 0.00M | NA | NA | NA |
Year over Year Growth Est. | NA | NA | NA | NA |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -2.44 | -1.54 | -7.48 | -5.87 |
# of Estimates | 1 | 1 | 1 | 1 |
Most Recent Consensus | -2.44 | -1.54 | -7.48 | -5.87 |
High Estimate | -2.44 | -1.54 | -7.48 | -5.87 |
Low Estimate | -2.44 | -1.54 | -7.48 | -5.87 |
Year ago EPS | -2.85 | NA | -225.94 | -7.48 |
Year over Year Growth Est. | 14.39% | NA | 96.69% | 21.52% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 0 | 0 | 0 | 0 |
Up Last 60 Days | 0 | 0 | 0 | 0 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 1 | 1 | 1 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -2.44 | -1.54 | -7.48 | -5.87 |
7 Days Ago | -2.44 | -1.54 | -7.48 | -5.87 |
30 Days Ago | -2.44 | -1.54 | -7.48 | -5.87 |
60 Days Ago | -1.46 | -1.53 | -6.78 | -5.28 |
90 Days Ago | -1.46 | -1.53 | -6.78 | -5.28 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -2.44 | -1.54 | -7.48 | -5.87 |
Zacks Consensus Estimate | -2.44 | -1.54 | -7.48 | -5.87 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -2.23 | -2.02 | NA | -2.85 | NA |
Estimate | -2.10 | -3.59 | NA | -3.15 | NA |
Difference | -0.13 | 1.57 | NA | 0.30 | 0.58 |
Surprise | -6.19% | 43.73% | NA | 9.52% | 15.69% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more